{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:34:51Z","timestamp":1789688091293,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["17326"],"award-info":[{"award-number":["17326"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jcyt.2023.02.008","type":"journal-article","created":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T07:28:12Z","timestamp":1680334092000},"page":"605-614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cells"],"prefix":"10.1016","volume":"25","author":[{"given":"Giulia","family":"Casari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Dall'Ora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6164-289X","authenticated-orcid":false,"given":"Aurora","family":"Melandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1708-8785","authenticated-orcid":false,"given":"Valentina","family":"Masciale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1551-7702","authenticated-orcid":false,"given":"Chiara","family":"Chiavelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6305-0350","authenticated-orcid":false,"given":"Malvina","family":"Prapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2035-8988","authenticated-orcid":false,"given":"Giovanni","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carlotta","family":"Spano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Murgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8133-0508","authenticated-orcid":false,"given":"Angela","family":"D'Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Baschieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Battista","family":"Ceccherelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4007-1503","authenticated-orcid":false,"given":"Massimo","family":"Dominici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0120-6129","authenticated-orcid":false,"given":"Giulia","family":"Grisendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2023.02.008_bib0001","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-1759(01)00501-4","article-title":"Development, characterization and use of monoclonal antibodies against sTRAIL: measurement of sTRAIL by ELISA","volume":"259","author":"Liabakk","year":"2002","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0002","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2567.2009.03058.x","article-title":"Following TRAIL's path in the immune system","volume":"127","author":"Falschlehner","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0003","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1084\/jem.191.7.1095","article-title":"Tumor necrosis factor\u2013related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression","volume":"191","author":"Song","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0004","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3390\/cancers11081161","article-title":"Interactions of tumor necrosis factor\u2013related apoptosis-inducing ligand (TRAIL) with the immune system: implications for inflammation and cancer","volume":"11","author":"Beyer","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/680749","article-title":"TRAIL modulates the immune system and protects against the development of diabetes","volume":"2015","author":"Bossi","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0006","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.0019-2805.2003.01794.x","article-title":"Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils","volume":"111","author":"Kamohara","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0007","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.4049\/jimmunol.0902797","article-title":"Dual effects of TRAIL in suppression of autoimmunity: the inhibition of Th1 cells and the promotion of regulatory T cells","volume":"185","author":"Ikeda","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0008","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3390\/cancers11050639","article-title":"TRAIL and FasL functions in cancer and autoimmune diseases: towards an increasing complexity","volume":"11","author":"Rossin","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0009","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.4049\/jimmunol.168.3.1356","article-title":"Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice","volume":"168","author":"Cretney","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0010","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/JLB.MR0718-269R","article-title":"Mechanisms of natural killer cell-mediated cellular cytotoxicity","volume":"105","author":"Prager","year":"2019","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0011","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.3389\/fimmu.2019.01530","article-title":"Multiple interactions between cancer cells and the tumor microenvironment modulate TRAIL signaling: implications for TRAIL receptor targeted therapy","volume":"10","author":"de Looff","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0012","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/cdd.2014.81","article-title":"Getting TRAIL back on track for cancer therapy","volume":"21","author":"Lemke","year":"2014","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0013","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrc3798","article-title":"Stem cell-based therapies for cancer treatment: separating hope from hype","volume":"14","author":"Stuckey","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0014","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/ijc.29442","article-title":"Engineered adenoviruses combine enhanced oncolysis with improved virus production by mesenchymal stromal carrier cells: oncolytic adenoviruses for MSC delivery to pancreatic cancer","volume":"137","author":"Hammer","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0015","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1158\/0008-5472.CAN-09-1865","article-title":"Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor\u2013related apoptosis-inducing ligand delivery for cancer therapy","volume":"70","author":"Grisendi","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0016","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/stem.1903","article-title":"Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas","volume":"33","author":"Grisendi","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0017","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1089\/hum.2014.039","article-title":"Surrounding pancreatic adenocarcinoma by killer mesenchymal stromal\/stem cells","volume":"25","author":"Golinelli","year":"2014","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0018","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/s41598-018-37433-6","article-title":"Soluble TRAIL armed human MSC as gene therapy for pancreatic cancer","volume":"9","author":"Spano","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0019","doi-asserted-by":"crossref","first-page":"436","DOI":"10.7150\/thno.27576","article-title":"MSC-delivered soluble TRAIL and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma","volume":"9","author":"Rossignoli","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0020","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41417-018-0062-x","article-title":"Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors","volume":"27","author":"Golinelli","year":"2020","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101240","article-title":"Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma","volume":"15","author":"Golinelli","year":"2022","journal-title":"Transl Oncol"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0022","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/j.biochi.2013.07.015","article-title":"Proteomic techniques for characterisation of mesenchymal stem cell secretome","volume":"95","author":"Kupcova Skalnikova","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0023","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/1097-0320(20010501)44:1<57::AID-CYTO1082>3.0.CO;2-O","article-title":"Supravital exposure to propidium iodide identifies apoptosis on adherent cells","volume":"44","author":"Zamai","year":"2001","journal-title":"Cytometry"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0024","doi-asserted-by":"crossref","first-page":"12347","DOI":"10.3390\/s120912347","article-title":"Multiple applications of Alamar Blue as an indicator of metabolic function and cellular health in cell viability bioassays","volume":"12","author":"Rampersad","year":"2012","journal-title":"Sensors"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0025","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/cgt.2012.46","article-title":"TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells","volume":"19","author":"Moniri","year":"2012","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0026","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1111\/febs.15637","article-title":"The multifaceted role of TRAIL signaling in cancer and immunity","volume":"288","author":"Cardoso Alves","year":"2021","journal-title":"FEBS J"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0027","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1084\/jem.189.8.1343","article-title":"Monocyte-mediated tumoricidal activity via the tumor necrosis factor\u2013related cytokine, TRAIL","volume":"189","author":"Griffith","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0028","doi-asserted-by":"crossref","first-page":"41662","DOI":"10.18632\/oncotarget.9340","article-title":"Functional TRAIL receptors in monocytes and tumor-associated macrophages: A possible targeting pathway in the tumor microenvironment","volume":"7","author":"Liguori","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.jcyt.2023.02.008_bib0029","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/JLB.4RI0818-311R","article-title":"Monocyte heterogeneity and functions in cancer","volume":"106","author":"Olingy","year":"2019","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.994319","article-title":"Monocyte programming by cancer therapy","volume":"13","author":"Patysheva","year":"2022","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.jcyt.2023.02.008_bib0031","doi-asserted-by":"crossref","first-page":"e702","DOI":"10.1038\/cddis.2013.214","article-title":"Resistance to TRAIL in non-transformed cells is due to multiple redundant pathways","volume":"4","author":"van Dijk","year":"2013","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.jcyt.2023.02.008_bib0032","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0014-5793(00)02042-1","article-title":"Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types","volume":"482","author":"Zhang","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0033","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nri3209","article-title":"Multipotent mesenchymal stromal cells and the innate immune system","volume":"12","author":"Le Blanc","year":"2012","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0034","first-page":"3890","article-title":"MSC: immunoregulatory effects, roles on neutrophils and evolving clinical potentials","volume":"11","author":"Joel","year":"2019","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0035","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/(SICI)1521-4141(199809)28:09<2714::AID-IMMU2714>3.0.CO;2-9","article-title":"Involvement of APO2 ligand\/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells","volume":"28","author":"Mart\u00ednez-Lorenzo","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0036","doi-asserted-by":"crossref","first-page":"18099","DOI":"10.1073\/pnas.0507329102","article-title":"Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis","volume":"102","author":"Clancy","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0037","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1182\/blood-2004-04-1294","article-title":"Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity","volume":"104","author":"Mirandola","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0038","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.cdd.4400692","article-title":"Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells","volume":"7","author":"Wendling","year":"2000","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0039","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.4049\/jimmunol.168.10.4881","article-title":"Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto)antigen-specific T cells","volume":"168","author":"L\u00fcnemann","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0040","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1006\/bbrc.2002.6452","article-title":"IFN-\u03b3 inhibition of TRAIL-induced IAP-2 upregulation, a possible mechanism of IFN-\u03b3-enhanced TRAIL-induced apoptosis","volume":"291","author":"Park","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0041","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1111\/j.1432-1033.2004.04362.x","article-title":"IFN-\u03b3 enhances TRAIL-induced apoptosis through IRF-1: IFN-\u03b3 enhances TRAIL-induced apoptosis","volume":"271","author":"Park","year":"2004","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0042","doi-asserted-by":"crossref","first-page":"e16241","DOI":"10.1371\/journal.pone.0016241","article-title":"TNF\u03b1 cooperates with IFN-\u03b3 to repress Bcl-xL expression to sensitize metastatic colon carcinoma cells to TRAIL-mediated apoptosis","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0043","doi-asserted-by":"crossref","first-page":"552","DOI":"10.4252\/wjsc.v6.i5.552","article-title":"Secretion of immunoregulatory cytokines by mesenchymal stem cells","volume":"6","author":"Kyurkchiev","year":"2014","journal-title":"World J Stem Cells"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0044","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1590\/0074-0276130252","article-title":"Vascular endothelial growth factor-A enhances indoleamine 2,3-dioxygenase expression by dendritic cells and subsequently impacts lymphocyte proliferation","volume":"109","author":"Marti","year":"2014","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0045","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1080\/14653240903079377","article-title":"Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6","volume":"11","author":"Najar","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0046","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cyto.2015.11.016","article-title":"Inflammatory cytokines regulate secretion of VEGF and chemokines by human conjunctival fibroblasts: role in dysfunctional tear syndrome","volume":"78","author":"Nagineni","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.jcyt.2023.02.008_bib0047","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/SHK.0b013e31820b2fb9","article-title":"IL-6 and TGF-\u03b1 costimulate mesenchymal stem cell vascular endothelial growth factor production by ERK-, JNK-, and PI3K-mediated mechanisms","volume":"35","author":"Herrmann","year":"2011","journal-title":"Shock"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324923000610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324923000610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:49:27Z","timestamp":1761443367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324923000610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1465324923000610"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2023.02.008","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cells","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2023.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society for Cell & Gene Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}